tiprankstipranks
Trending News
More News >
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Ratios

Compare
1,324 Followers

Madrigal Pharmaceuticals Ratios

MDGL's free cash flow for Q3 2025 was $0.94. For the 2025 fiscal year, MDGL's free cash flow was decreased by $ and operating cash flow was $-0.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.44 6.10 5.38 3.12 3.54
Quick Ratio
3.26 5.90 5.38 3.12 3.54
Cash Ratio
0.76 0.59 0.84 2.86 0.47
Solvency Ratio
-0.39 -1.61 -1.59 -1.81 -3.12
Operating Cash Flow Ratio
-0.41 -2.69 -2.74 -1.94 -2.39
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 -448.58
Net Current Asset Value
$ 609.96M$ 745.06M$ 402.07M$ 196.19M$ 194.46M
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.11 0.18 0.14 <0.01
Debt-to-Equity Ratio
0.55 0.16 0.29 0.25 <0.01
Debt-to-Capital Ratio
0.36 0.14 0.22 0.20 <0.01
Long-Term Debt-to-Capital Ratio
0.35 0.13 0.22 0.20 0.00
Financial Leverage Ratio
2.18 1.38 1.58 1.84 1.39
Debt Service Coverage Ratio
-15.43 -30.68 -29.89 -74.94 -588.56
Interest Coverage Ratio
-17.56 -33.94 -29.93 -74.06 0.00
Debt to Market Cap
0.03 0.02 0.03 <0.01 <0.01
Interest Debt Per Share
16.19 6.31 6.95 3.14 0.05
Net Debt to EBITDA
-0.19 -0.04 -0.05 0.96 0.15
Profitability Margins
Gross Profit Margin
95.25%96.54%0.00%0.00%0.00%
EBIT Margin
-36.67%-250.49%0.00%0.00%0.00%
EBITDA Margin
-36.47%-249.88%0.00%0.00%0.00%
Operating Profit Margin
-41.52%-276.39%0.00%0.00%0.00%
Pretax Profit Margin
-39.04%-258.64%0.00%0.00%0.00%
Net Profit Margin
-39.04%-258.64%0.00%0.00%0.00%
Continuous Operations Profit Margin
-39.04%-258.64%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%101.34%99.68%
EBT Per EBIT
94.03%93.58%98.20%100.61%99.74%
Return on Assets (ROA)
-21.22%-44.70%-58.33%-82.55%-88.20%
Return on Equity (ROE)
-41.50%-61.76%-92.18%-151.64%-122.93%
Return on Capital Employed (ROCE)
-31.67%-57.03%-72.89%-119.01%-123.40%
Return on Invested Capital (ROIC)
-31.63%-56.97%-72.82%-120.31%-122.50%
Return on Tangible Assets
-21.34%-44.90%-58.33%-82.55%-88.20%
Earnings Yield
-2.68%-7.10%-8.64%-6.02%-17.21%
Efficiency Ratios
Receivables Turnover
6.54 3.35 0.00 0.00 0.00
Payables Turnover
0.78 0.14 0.02 0.02 0.02
Inventory Turnover
0.51 0.18 0.00 0.00 0.00
Fixed Asset Turnover
89.23 39.24 0.00 0.00 0.00
Asset Turnover
0.54 0.17 0.00 0.00 0.00
Working Capital Turnover Ratio
0.84 0.26 0.00 0.00 0.00
Cash Conversion Cycle
308.99 -449.07 -19.42K -18.63K -19.27K
Days of Sales Outstanding
55.83 109.06 0.00 0.00 0.00
Days of Inventory Outstanding
719.89 1.99K 0.00 0.00 0.00
Days of Payables Outstanding
466.74 2.55K 19.42K 18.63K 19.27K
Operating Cycle
775.72 2.10K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-7.14 -21.42 -17.35 -13.12 -11.12
Free Cash Flow Per Share
-7.19 -21.48 -17.43 -13.13 -11.14
CapEx Per Share
0.05 0.07 0.08 0.01 0.01
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-152.64 -311.61 -219.22 -1.04K -879.99
Capital Expenditure Coverage Ratio
-152.64 -311.61 -219.22 -1.04K -879.99
Operating Cash Flow Coverage Ratio
-0.46 -3.81 -2.77 -4.51 -230.76
Operating Cash Flow to Sales Ratio
-0.22 -2.53 0.00 0.00 0.00
Free Cash Flow Yield
-1.48%-6.96%-7.53%-4.52%-13.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-37.36 -14.09 -11.57 -16.62 -5.81
Price-to-Sales (P/S) Ratio
14.73 36.44 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
17.26 8.70 10.67 25.20 7.15
Price-to-Free Cash Flow (P/FCF) Ratio
-67.51 -14.36 -13.28 -22.10 -7.61
Price-to-Operating Cash Flow Ratio
-67.27 -14.41 -13.34 -22.12 -7.62
Price-to-Earnings Growth (PEG) Ratio
30.00 -1.47 -0.80 -0.84 -0.41
Price-to-Fair Value
17.26 8.70 10.67 25.20 7.15
Enterprise Value Multiple
-40.58 -14.63 -11.43 -16.01 -5.64
Enterprise Value
10.96B 6.58B 4.34B 4.69B 1.37B
EV to EBITDA
-40.58 -14.63 -11.43 -16.01 -5.64
EV to Sales
14.80 36.55 0.00 0.00 0.00
EV to Free Cash Flow
-67.82 -14.41 -13.33 -20.85 -7.42
EV to Operating Cash Flow
-68.27 -14.45 -13.39 -20.87 -7.43
Tangible Book Value Per Share
27.50 35.24 21.69 11.52 11.86
Shareholders’ Equity Per Share
27.83 35.46 21.69 11.52 11.86
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 -0.01 <0.01
Revenue Per Share
32.94 8.47 0.00 0.00 0.00
Net Income Per Share
-12.86 -21.90 -19.99 -17.47 -14.58
Tax Burden
1.00 1.00 1.00 1.01 1.00
Interest Burden
1.06 1.03 0.98 1.01 1.00
Research & Development to Revenue
0.40 1.31 0.00 0.00 0.00
SG&A to Revenue
0.28 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.12 0.44 0.00 0.00 0.00
Income Quality
0.56 0.98 0.87 0.76 0.76
Currency in USD